Document Detail

Cardioprotection with adenosine: 'a riddle wrapped in a mystery'.
MedLine Citation:
PMID:  15895103     Owner:  NLM     Status:  MEDLINE    
Review of the published literature on adenosine and cardioprotection could lead one to paraphrase the famous words of Sir Winston Churchill (Radio broadcast, 1 October 1939 (in reference to Russia)) and conclude: 'I cannot forecast to you the action of adenosine. It is a riddle wrapped in a mystery inside an enigma'. That is, although it is well-established that adenosine can render cardiomyocytes resistant to lethal ischemia/reperfusion-induced injury, new and intriguing insights continue to emerge as to the mechanisms by which adenosine might limit myocardial infarct size.
Karin Przyklenk; Peter Whittaker
Related Documents :
22851543 - Association between extracellular matrix expansion quantified by cardiovascular magneti...
4092373 - The effects of nifedipine on the systemic and coronary vascular beds of the sheep: a po...
1167743 - The effects of ketamine and of innovar anesthesia on digitalis tolerance in dogs.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  British journal of pharmacology     Volume:  145     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-07-18     Completed Date:  2005-10-28     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  699-700     Citation Subset:  IM    
Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / pharmacology*
Cardiotonic Agents / pharmacology*
Myocardial Infarction / prevention & control*
Myocardial Reperfusion Injury / prevention & control
Nitric Oxide / metabolism
Nitric Oxide Synthase / antagonists & inhibitors
Reg. No./Substance:
0/Cardiotonic Agents; 10102-43-9/Nitric Oxide; 58-61-7/Adenosine; EC Oxide Synthase
Comment On:
Br J Pharmacol. 2005 Jul;145(6):703-11   [PMID:  15895104 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in per...
Next Document:  Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.